Summit Therapeutics, Inc. (SMMT)
16.38
-0.07
(-0.43%)
USD |
NASDAQ |
Sep 24, 16:00
16.40
+0.02
(+0.12%)
Pre-Market: 08:08
Summit Therapeutics Gross Profit (Annual) : -0.146M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.146M |
| December 31, 2024 | -0.089M |
| December 31, 2023 | -2.05M |
| December 31, 2022 | -1.809M |
| December 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| January 31, 2018 | 0.00 |
| January 31, 2017 | 3.011M |
| January 31, 2016 | 0.8276M |
| January 31, 2015 | 0.00 |
| Date | Value |
|---|---|
| January 31, 2014 | 2.114M |
| January 31, 2013 | 2.734M |
| January 31, 2012 | 2.524M |
| January 31, 2011 | 0.484M |
| January 31, 2010 | -3.432M |
| January 31, 2009 | -3.068M |
| January 31, 2008 | 0.2322M |
| January 31, 2007 | 0.6571M |
| January 31, 2006 | 0.5388M |
| January 31, 2005 | 0.0413M |
| January 31, 2004 | 0.0012M |
| January 31, 2003 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | -0.199M |
| Kezar Life Sciences, Inc. | -0.897M |
| Protara Therapeutics, Inc. | -0.362M |
| Clene, Inc. | -1.338M |